Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

The effect of deprenyl and levadopa on the progression of Parkinson’s Disease,

Go back to Resources

The effect of deprenyl and levadopa on the progression of Parkinson’s Disease,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Steady improvement in renal allograft survival among North American children. A five year appraisal by the North American Pediatric Renal Transplant Cooperative Study,

Go back to Resources

Steady improvement in renal allograft survival among North American children. A five year appraisal by the North American Pediatric Renal Transplant Cooperative Study,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Steady improvement in cadaver graft survival (GS) among North American children. A 5-year appraisal by the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Go back to Resources

Steady improvement in cadaver graft survival (GS) among North American children. A 5-year appraisal by the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Authors:

Location:

Go back to Resources

Serious cytomegalovirus (CMV) infections following pediatric renal transplantation (RTx): II. Short and long-term effects of viral prophylaxis (PX),

Go back to Resources

Serious cytomegalovirus (CMV) infections following pediatric renal transplantation (RTx): II. Short and long-term effects of viral prophylaxis (PX),

Authors:

Go back to Resources

Serious cytomegalovirus (CMV) infections following pediatric renal transplantation (RTx): I. Changing patterns and risk factors,

Go back to Resources

Serious cytomegalovirus (CMV) infections following pediatric renal transplantation (RTx): I. Changing patterns and risk factors,

Authors:

Go back to Resources

Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eye,

Go back to Resources

Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eye,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Clinical trials referral resource. High priority trials.

Go back to Resources

Clinical trials referral resource. High priority trials.

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Clinical trials referral resource. Clinical trials with tomudex,

Go back to Resources

Clinical trials referral resource. Clinical trials with tomudex,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Clinical trials referral resource. Clinical trials with PSC-833

Go back to Resources

Clinical trials referral resource. Clinical trials with PSC-833

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Clinical Trials Referral Resource. Clinical trials with prillyl alcohol.

Go back to Resources

Clinical Trials Referral Resource. Clinical trials with prillyl alcohol.

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 117
  • Page 118
  • Page 119
  • Page 120
  • Current page 121
  • Page 122
  • Page 123
  • Page 124
  • Page 125
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification